Hantavirus IgG ELISA Kit (Human) (OKNA00138)

Catalog No: OKNA00138

Size:96 Wells

Product Info

• Predicted Species Reactivity: Human
• ELISA Kit Detection Method: Colorimetric, OD450 nm
• ELISA Kit Duration: ~3 Hours
• ELISA Kit Principle: Aviva Systems Biology Hantavirus IgG ELISA Kit (Human) (OKNX00138) is based on standard reverse capture sandwich enzyme-linked immuno-sorbent assay technology. Hantavirus antigen has been pre-coated and blocked in a 96-wellplate (12 x 8 Well Strips). Standards or test samples are added to the wells, incubated and washed. An HRP conjugated detector antibody specific for Human IgG is added, incubated and followed by washing. An enzymatic reaction is produced through the addition of substrate which is catalyzed by HRP generating a blue color product that changes to yellow after adding acidic stop solution. The density of yellow coloration is read by absorbance at 450 nm and is qualitatively proportional to the amount of sample anti-Hantavirus IgG captured the in well.
• ELISA Kit Reproducibility:

  Metric	Sample Type	n=	CV%
  Inter-Assay	Negative Serum	24	5.04	0.0844
  Inter-Assay	Positive Serum	24	24.74	0.042
  Inter-Assay	Positive Serum	24	29.89	0.048
  Intra-Assay	Negative Serum	24	0.315	0.1029
  Intra-Assay	Positive Serum	24	1.283	0.0568
  Intra-Assay	Positive Serum	24	0.731	0.0559

• ELISA Kit Component:
  • Hantavirus IgG Well Plate: 96 Wells (12 x 8 Well Strips)
  • IgG Sample Diluent: 1 x 100 mL
  • Stop Solution: 1 x 15 mL
  • 20X Wash Solution: 1 x 50 mL
  • Anti-IgG HRP Conjugate: 1 x 20 mL
  • TMB Substrate: 1 x 15 mL
  • Hantavirus Positive Control: 1 x 2 mL
  • Hantavirus Cut-Off Control: 1 x 3 mL
  • Hantavirus Negative Control: 1 x 2 mL
• Reconstitution and Storage: Store as indicated in product manual.
• Sample Type: Serum, Plasma
• Sensitivity: Sensitivity is determined as the probability of the assay indicating a positive score in samples with the specific analyte present: > 95.9%
• Specificity: Specificity is determined as the probability of the assay indicating a negative score in samples absent of the specific analyte: 98.3%
• Assay Info: Assay Methodology: Quantitative Reverse Capture Sandwich ELISA

Target Info

• Protein Name: Hantavirus IgG
• Description of Target: Hantaviruses are negative sense RNA viruses in the Bunyaviridae family. Humans may be infected with Hantaviruses through urine, saliva or contact with rodent waste products. Some Hantaviruses cause potentially fatal diseases in humans, such as hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS), but others have not been associated with human disease. Human infections of Hantaviruses have almost entirely been linked to human contact with rodent excrement, but recent human-to-human transmission has been reported with the Andes virus in South America. Hantavirus has an incubation time of two to four weeks in humans before symptoms of infection occur. The symptoms of HFRS can be split into five phases: • Febrile phase: Symptoms include fever, chills, sweaty palms, diarrhea, malaise, headaches, nausea, abdominal and back pain, respiratory problems such as the ones common in influenza virus infection, as well as gastro-intestinal problems. These symptoms normally occur for three to seven days and arise about two to three weeks after exposure. • Hypotensive phase: This occurs when the blood platelet levels drop and symptoms can lead to tachycardia and hypoxemia. This phase can last for 2 days. • Oliguric phase: This phase lasts for three to seven days and is characterized by the onset of renal failure and proteinuria occurs. • Diuretic phase: This is characterized by diuresis of three to six liters per day, which can last for a couple of days up to weeks. • Convalescent phase: This is normally when recovery occurs and symptoms begin to improve. Regions especially affected by HFRS include China, the Korean Peninsula, Russia (Hantaan, Puumala and Seoul viruses), and northern and western Europe (Puumala and Dobrava virus).